UFR des Sciences Pharmaceutiques, Université de Caen Basse-Normandie, EA 4258 CERMN, FR CNRS 3038 INC3M, SF-4206 ICORE, Boulevard Becquerel, F-14032 Caen, France.
J Med Chem. 2012 Nov 26;55(22):9693-707. doi: 10.1021/jm300943r. Epub 2012 Nov 9.
The work described herein aims at finding new potential ligands for the brain imaging of 5-HT(4) receptors (5-HT(4)Rs) using single-photon emission computed tomography (SPECT). Starting from the nonsubstituted phenanthridine compound 4a, exhibiting a K(i) value of 51 nM on the 5-HT(4)R, we explored the structure-affinity in this series. We found that substitution in position 4 of the tricycle with a fluorine atom gave the best result. Introduction of an additional nitrogen atom inside the tricyclic framework led to an increase of both the affinity and selectivity for 5-HT(4)R, suggesting the design of the antagonist 4v, exhibiting a high affinity of 0.04 nM. Several iodinated analogues were then synthesized as potential SPECT tracers. The iodinated compound 11d was able to displace the reference radioiodinated 5-HT(4)R antagonist (1-butylpiperidin-4-yl)methyl-8-amino-7-iodo[(123)I]-2,3-dihydrobenzo[b][1,4]dioxine-5-carboxylate {[(123)I]1, [(123)I]SB 207710} both in vitro and in vivo in brain. Compound 11d was radiolabeled with [(125)I]iodine, providing a potential SPECT candidate for brain imaging of 5-HT(4)R.
本文旨在通过单光子发射计算机断层扫描(SPECT)寻找新的潜在配体,用于脑成像 5-HT(4)受体(5-HT(4)Rs)。从非取代的菲啶化合物 4a 开始,其对 5-HT(4)R 的 K(i)值为 51 nM,我们在此系列中探索了结构-亲和力。我们发现三环中 4 位的取代氟原子效果最佳。在三环骨架内引入额外的氮原子会导致对 5-HT(4)R 的亲和力和选择性增加,这表明设计出的拮抗剂 4v 具有高亲和力,为 0.04 nM。然后合成了几种碘化类似物作为潜在的 SPECT 示踪剂。碘化化合物 11d 能够在体外和体内脑中置换参考放射性碘标记的 5-HT(4)R 拮抗剂[(123)I]1-丁基哌啶-4-基甲基-8-氨基-7-碘-[(123)I]-2,3-二氢苯并[b][1,4]二恶嗪-5-羧酸酯{[(123)I]1, [(123)I]SB 207710}。化合物 11d 用 [(125)I]碘标记,为脑成像 5-HT(4)R 提供了潜在的 SPECT 候选物。